Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 16,659,000 | 16,887,000 | 18,271,000 | 22,385,000 | 21,903,000 |
| Cost of Goods | 8,933,000 | 9,351,000 | 9,975,000 | 11,770,000 | 10,044,000 |
| Gross Profit | 7,726,000 | 7,537,000 | 8,296,000 | 10,615,000 | 11,859,000 |
| Operating Expenses | 11,297,000 | 7,980,000 | 6,906,000 | 28,099,000 | 9,705,000 |
| Operating Income | -3,571,000 | -444,000 | 1,390,000 | -17,484,000 | 2,154,000 |
| Other Income | -697,000 | -834,000 | -4,057,000 | -898,000 | -1,322,000 |
| Pre-tax Income | -4,268,000 | -1,278,000 | -2,667,000 | -18,382,000 | 832,000 |
| Income Tax | -168,000 | -278,000 | -195,000 | -1,933,000 | 521,000 |
| Net Income Continuous | -4,100,000 | -1,000,000 | -2,472,000 | -16,449,000 | 311,000 |
| Minority Interests | -109,000 | -2,000 | -322,000 | -184,000 | -18,000 |
| Net Income | $-3,990,000 | $-998,000 | $-2,150,000 | $-16,265,000 | $329,000 |
| EPS Basic Total Ops | -3.64 | -0.91 | -2.35 | -16.26 | 0.07 |
| EPS Basic Continuous Ops | -3.74 | -0.92 | -2.42 | -16.19 | 0.33 |
| EPS Diluted Total Ops | -3.64 | -0.91 | -2.35 | -16.26 | 0.07 |
| EPS Diluted Continuous Ops | -3.74 | -0.92 | -2.42 | -16.19 | 0.32 |
| EPS Diluted Before Non-Recurring Items | 2.45 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,014,000 | $1,278,000 | $3,232,000 | $-15,372,000 | $3,678,000 |